Evidence map›Paper›PMID 34685389›Full record

ArticleLife (Basel, Switzerland)2021

The Ginsenoside Rg

Chu-Kuang Chou, Yu-Shen Huang, Pei-Yu Lin, Kazuhiro Imai, Shih-Ming Chen, Jen-Ai Lee

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Chu-Kuang ChouDivision of Gastroenterology and Hepatology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi 60002, Taiwan.ORCID 0000-0003-2588-6883
Yu-Shen HuangSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Pei-Yu LinDepartment of Pharmacy, National Yang Ming Chiao Tung University Hospital, Yilan 26042, Taiwan.
Kazuhiro ImaiResearch Institute of Pharmaceutical Sciences, Musashino University, Tokyo 180-8777, Japan.
Shih-Ming ChenSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Jen-Ai LeeSchool of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-6080-8736
Taipei Medical University · TWChia-Yi Christian Hospital · TWMusashino University · JPNational Yang Ming Chiao Tung University · TW

Funding

Ditmanson Medical Foundation Chia-Yi Christian Hospital R105-20, 2016
6 · The paper itself

Abstract

Chronic exposure to aristolochic acid (AA) leads to renal interstitial fibrosis and nephropathy. In this study, we aimed to investigate the renoprotective effects of

Indexed as

aristolochic acidginsenosidemitochondrial disordernephropathyRg1

Identifiers

PMID34685389
PMCPMC8539135
OpenAlexW3204623841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.